Testing an iodine-like PET/CT scan for thyroid cancer
Part of Cancer, Hormones & metabolism clinical trials.
This study checks how well a new PET/CT scan (18F-TFB) can find thyroid cancer after a standard iodine whole-body scan. It may help doctors see where the cancer is using an added imaging test, which could improve planning for care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have biopsy-proven papillary or follicular thyroid cancer
- Your doctor recommends a standard whole-body iodine scan (123I-SPECT/CT)
- You agree to have the 18F-TFB PET/CT scan after the iodine scan
- You’re age 18 or older and can stay still lying down for about 65 minutes
- You can understand and sign the informed consent form, and you are not pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of PET scan (F-18 Tetrafluoroborate) to find thyroid cancer cells that don't show up on standard scans. It's for people who have had surgery and radioactive iodine therapy but still have signs of cancer in their blood tests.
This trial tests whether a new type of scan (I-124 PET/CT) can better detect thyroid cancer compared to standard scans. It may help doctors decide on the best treatment, such as radiation therapy or surgery.
This trial tests how much radiation a specialized whole-body PET/CT scan delivers in patients with differentiated thyroid cancer. It may help doctors better plan treatment for cancer that persists, returns, or has spread—especially when radioactive iodine (RAI) may or may not work.
This study tests a new type of PET scan to find thyroid cancer that has come back or spread. It compares two tracers to see which one better shows the cancer, which may help doctors choose the right treatment.
This early-stage study tests how well a special iodine scan (using iodine-124) can help plan treatment with radioactive iodine (iodine-131) for thyroid cancer that has spread. It may help doctors decide the right way to measure and target radioiodine-avid (radioiodine-absorbing) metastases.
This study compares two types of scanning cameras to see how well they record images in people with thyroid cancer treated with iodine 131. It may help improve which camera gives clearer results after this treatment.
Hear when a new Thyroid Gland Follicular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.